Viatris, which Pfizer created in 2020, voluntarily withdrew extended-release products made at a plant in Ireland after an ...
Global alignment of generics’ regulation is crucial for affordable, high-quality medication: Dr Tumbagi: Nandita Vijayasimha, Bengaluru Saturday, May 2, 2026, 08:00 Hrs [IST] In ...
A new device analyzes pill dissolution rates to generate digital fingerprints that distinguish real from counterfeit drugs.
A Quinnipiac poll in March found that 70 percent of Americans think that artificial intelligence will lead to fewer job ...
Viatris initiated a voluntary recall of Xanax XR Lot 8177156 on March 17 after testing showed the tablets did not meet required dissolution specifications. The Food and Drug Administration has listed ...
Bottles of a popular anxiety medication are under recall nationwide for failing to meet dissolution requirements, the Food and Drug Administration said. In a recall notice on April 8, pharmaceutical ...
Journalist - Aaron joins the Simple Flying team with 14 years of experience in the travel & tourism industry. He has a ...
The anxiety medication is being recalled due to "failed dissolution specifications." ...
The European Commission's EU Inc. proposal takes meaningful steps toward harmonising winding-up procedures across the Single ...
A specific batch of extended-release Xanax failed a key quality test.
The successful tech transfer of the manufacturing and analytical capability for AD04 to a new CDMO resulted in significant efficiencies and crossing the hurdle of dissolution, blend and content ...
Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD ; OTCQB: STLNF ; FSE: B76) Stallion Uranium is pleased to ...